Skip to main content
ABT logo
ABT
(NYSE)
Abbott Laboratories
$116.64-- (--)
Loading... - Market loading

Abbott Laboratories (ABT) Stock Price & Financial Analysis

Abbott Laboratories Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$113.45 - $116.66
52-Week High$137.49
52-Week Low$81.97
Open$114.02
Volume9.83M
Average Volume (3M)10.31M
Market Cap199.45B
Shares Outstanding1.74B
P/E Ratio (TTM)35.46
Forward P/E71.06
Price to Sales (P/S)4.13
Price to Book (P/B)1.86
EV/EBITDA19.55
Revenue (TTM)46.59B
Net Income (TTM)5.42B
Free Cash Flow (TTM)7.82B
EPS (TTM)$3.11
Profit Margin11.65%
Operating Margin15.77%
Return on Equity (ROE)5.24%
Debt to Equity0.29
50-Day MA$98.45
200-Day MA$107.22
52-Week Change-15.28%
Annual Dividend$2.48
Dividend Yield2.25%
Payout Ratio79.84%
Last Dividend Ex-DateJul 15, 2026

Frequently Asked Questions About Abbott Laboratories

What is the current stock price for ABT?

As of the latest trading session, ABT stock trades at $116.64. The 52-week range is $81.97–$137.49, with a day range of $113.45–$116.66.

What is the P/E ratio for ABT?

Abbott Laboratories's trailing P/E ratio is 35.5, meaning investors pay $35.5 for every $1 of annual earnings. The forward P/E is 71.1, reflecting analyst expectations for future earnings. Abbott Laboratories operates in the Healthcare sector.

Does ABT pay dividends?

Yes, Abbott Laboratories pays a 2.25% annual dividend yield ($2.48 per share). The payout ratio is 79.8%. The last ex-dividend date was 2026-07-15.

What do analysts recommend for ABT?

Based on 11 analysts, the consensus for ABT is Buy.

What is the market cap of ABT?

Abbott Laboratories's market capitalization is $203.30B, classifying it as a mega-cap company. Abbott Laboratories operates in the Healthcare sector within the Medical Devices industry.